Insider · CIK 0001646423
Richard M. Wright
Files at CLDX (Celldex Therapeutics, Inc.). First filing Nov 17, 2025, latest Nov 17, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CLDX: Celldex Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | CLDXsell Celldex Therapeutics, Inc. | $1.2M 49,298 shares | -70% | +57% from low-16% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | CLDX Celldex Therapeutics, Inc. | MOption exercise Common Stock | +6,876 | $9.02 | $62k | 27,709 | Nov 17, 2025 |
| Nov 13, 2025 | CLDX Celldex Therapeutics, Inc. | MOption exercise Common Stock | +26,672 | $10.38 | $277k | 54,381 | Nov 17, 2025 |
| Nov 13, 2025 | CLDX Celldex Therapeutics, Inc. | MOption exercise Common Stock | +15,750 | $22.48 | $354k | 70,131 | Nov 17, 2025 |
| Nov 13, 2025 | CLDX Celldex Therapeutics, Inc. | SOpen-market sale Common Stock | -49,298 | $24.00 | $1.2M | 20,833 | Nov 17, 2025 |
| Nov 13, 2025 | CLDX Celldex Therapeutics, Inc. | MOption exercise Incentive Stock Optionderivative | -6,876 | $0.00 | $0 | 0 | Nov 17, 2025 |
| Nov 13, 2025 | CLDX Celldex Therapeutics, Inc. | MOption exercise Incentive Stock Optionderivative | -26,672 | $0.00 | $0 | 0 | Nov 17, 2025 |
| Nov 13, 2025 | CLDX Celldex Therapeutics, Inc. | MOption exercise Incentive Stock Optionderivative | -15,750 | $0.00 | $0 | 7,875 | Nov 17, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.